Physician

Jorge Eduardo Massare-Rodriguez, M.D.

According to 2025 Medicare claims, Jorge Massare-Rodriguez, M.D. (NPI: 1093973661) practices cardiac electrophysiology in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is REGIONAL CLINICS OF LONGVIEW (NPI: 1407047863; TIN: 20-4791426) and primary practice location at 75605-5128. Massare-Rodriguez is affiliated with the CHSPSC ACO 8, LLC (ACO ID: A3715), participating under the MSSP model.

Massare-Rodriguez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,503 traditional Medicare patients, billed 8,471 HCPCS/CPT codes, and received $485,635 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 4,534 prescription claims across 848 beneficiaries totaling $782,130 in drug costs, led by Eliquis (Apixaban). DME data shows 13 claims. Open Payments data shows 120 records totaling $9,754. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $319,150 to $782,130. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $23,604 and ending at $34,347.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,496	10,106	$628,132
2016	1,949	9,770	$534,836
2017	1,807	9,947	$563,431
2018	1,251	8,150	$504,833
2019	1,333	10,446	$575,786
2020	1,415	9,147	$540,431
2021	1,425	9,593	$589,401
2022	1,233	8,025	$541,704
2023	1,301	7,824	$471,986
2024	1,503	8,471	$485,635

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	569	4,821	$319,150
2016	633	4,600	$385,221
2017	602	4,204	$464,032
2018	548	3,691	$521,342
2019	600	3,732	$656,921
2020	659	3,951	$769,199
2021	716	4,087	$859,428
2022	736	3,915	$847,007
2023	838	4,196	$833,623
2024	848	4,534	$782,130

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	18	$35,468
2017	N/R	17	$36,266
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	13	$34,347

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	340	354	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	260	293	$85
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	343	1,168	$21
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	376	417	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	379	402	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	741	31,395	$601,403
Xarelto	Rivaroxaban	110	4,752	$85,865
Multaq	Dronedarone Hcl	23	1,065	$25,702
Flecainide Acetate	Flecainide Acetate	215	13,100	$6,433
Metoprolol Succinate	Metoprolol Succinate	551	30,555	$5,655

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0606	Automatic external defibrillator, with integrated electrocardiogram analysis, garment type	Y	N/R	13	$34,347

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	120	$9,754	Medical Device Business Services, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jorge Eduardo Massare-Rodriguez, M.D.?

Tedicare shows public-source Medicare data for Jorge Eduardo Massare-Rodriguez, M.D. (NPI 1093973661), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jorge Eduardo Massare-Rodriguez, M.D. have ACO affiliation data?

Jorge Eduardo Massare-Rodriguez, M.D. is shown with ACO affiliation data for CHSPSC ACO 8, LLC (MSSP, ACO ID A3715).

What billing organization is linked to Jorge Eduardo Massare-Rodriguez, M.D.?

Jorge Eduardo Massare-Rodriguez, M.D. is linked to REGIONAL CLINICS OF LONGVIEW (billing NPI 1407047863) in the available physician profile data.

Does Jorge Eduardo Massare-Rodriguez, M.D. have Open Payments data?

Jorge Eduardo Massare-Rodriguez, M.D. has 120 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.